Clinical Relevance of Tumor Cells with Stem-Like Properties in Pediatric Brain Tumors
Cécile Thirant(Délégation Paris 5), Marie‐Pierre Junier(Centre National de la Recherche Scientifique), C. Daumas‐Duport(Maternité Port Royal), A. Susini(Inserm), Anne-Laure Suréna(Délégation Paris 5), Ivan Bièche(Centre National de la Recherche Scientifique), Alexandra Bogeas(Délégation Paris 5), Jacques Grill(Institut Gustave Roussy), Chiara Villa(Centre National de la Recherche Scientifique), Hervé Chneiweiss(Centre National de la Recherche Scientifique), Françoise Pflumio(Inserm), Josette Cadusseau(Inserm), Nadine Léonard(Délégation Paris 5), Pascale Varlet(Inserm), Jeanne‐Marie Studler(Délégation Paris 5), Amélia Dias-Morais(Délégation Paris 5), Barbara Bessette(Délégation Paris 5), Silvina Dos Reis Tavares(Centre National de la Recherche Scientifique), Christian Sainte‐Rose(University Hospital of Lausanne), David C. Silvestre(Inserm), François D. Boussin(Inserm), Catherine Miquel(Inserm), Stéphanie Puget(Hôpital Necker-Enfants Malades)
Cited by 62
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
|Acta Neuropathologica|2015|676
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|The Lancet Neurology|2022|651
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
|Nature Genetics|2014|527